ES2616255T3 - Compuestos de pirimidina bicíclicos condensados como inhibidores de las aurora cinasas - Google Patents
Compuestos de pirimidina bicíclicos condensados como inhibidores de las aurora cinasas Download PDFInfo
- Publication number
- ES2616255T3 ES2616255T3 ES09739460.5T ES09739460T ES2616255T3 ES 2616255 T3 ES2616255 T3 ES 2616255T3 ES 09739460 T ES09739460 T ES 09739460T ES 2616255 T3 ES2616255 T3 ES 2616255T3
- Authority
- ES
- Spain
- Prior art keywords
- heterocycloalkyl
- heterocycloalkenyl
- heteroaryl
- aryl
- cycloalkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4906308P | 2008-04-30 | 2008-04-30 | |
| US49063 | 2008-04-30 | ||
| PCT/US2009/041382 WO2009134658A2 (en) | 2008-04-30 | 2009-04-22 | Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2616255T3 true ES2616255T3 (es) | 2017-06-12 |
Family
ID=41255689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES09739460.5T Active ES2616255T3 (es) | 2008-04-30 | 2009-04-22 | Compuestos de pirimidina bicíclicos condensados como inhibidores de las aurora cinasas |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8138194B2 (https=) |
| EP (1) | EP2276346B1 (https=) |
| JP (1) | JP5502072B2 (https=) |
| KR (1) | KR101667822B1 (https=) |
| CN (1) | CN102014627B (https=) |
| AU (1) | AU2009241469B2 (https=) |
| CA (1) | CA2722220C (https=) |
| DK (1) | DK2276346T3 (https=) |
| ES (1) | ES2616255T3 (https=) |
| PL (1) | PL2276346T3 (https=) |
| TW (1) | TWI363627B (https=) |
| WO (1) | WO2009134658A2 (https=) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102762571A (zh) * | 2009-12-23 | 2012-10-31 | 拜奥克里斯特制药公司 | 作为janus激酶抑制剂的杂环化合物 |
| AU2010339444A1 (en) | 2009-12-30 | 2012-07-19 | Arqule, Inc. | Substituted pyrrolo-aminopyrimidine compounds |
| WO2012061342A2 (en) | 2010-11-01 | 2012-05-10 | Arqule, Inc. | Substituted benzo-imidazo-pyrido-diazepine compounds |
| CN107082779A (zh) * | 2012-03-30 | 2017-08-22 | 理森制药股份公司 | 作为c‑met 蛋白激酶调节剂的新化合物 |
| CA2873967A1 (en) | 2012-05-21 | 2013-11-28 | Bayer Pharma Aktiengesellschaft | Substituted benzothienopyrimidines |
| HK1206723A1 (en) | 2012-05-21 | 2016-01-15 | Bayer Pharma Aktiengesellschaft | Thienopyrimidines |
| EP2852593A1 (en) | 2012-05-21 | 2015-04-01 | Bayer Pharma Aktiengesellschaft | Substituted pyrrolopyrimidines |
| EP2867236B1 (en) | 2012-06-29 | 2017-06-14 | Pfizer Inc | Novel 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors |
| TW201412740A (zh) | 2012-09-20 | 2014-04-01 | Bayer Pharma AG | 經取代之吡咯并嘧啶胺基苯并噻唑酮 |
| CN103664993B (zh) * | 2012-09-25 | 2016-05-25 | 韩冰 | 一类治疗缺血性脑损伤的化合物及其用途 |
| CN103012428A (zh) * | 2013-01-08 | 2013-04-03 | 中国药科大学 | 4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途 |
| JP2016514087A (ja) | 2013-02-01 | 2016-05-19 | バイエル・ファルマ・アクティエンゲゼルシャフト | 置換チエノピリミジンおよびその薬学的使用 |
| WO2014135480A1 (en) | 2013-03-06 | 2014-09-12 | Bayer Pharma Aktiengesellschaft | Substituted thiazolopyrimidines |
| EP3083618B1 (en) | 2013-12-17 | 2018-02-21 | Pfizer Inc | Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors |
| WO2015162515A1 (en) | 2014-04-25 | 2015-10-29 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
| FR3037956B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN105061460B (zh) * | 2015-08-18 | 2017-06-30 | 沈阳药科大学 | 含有硫醚结构的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用 |
| CN105061461B (zh) * | 2015-08-18 | 2017-06-30 | 沈阳药科大学 | 含有苄胺结构的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用 |
| RU2722149C1 (ru) | 2015-09-14 | 2020-05-27 | Пфайзер Инк. | Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2 |
| US9630968B1 (en) | 2015-12-23 | 2017-04-25 | Arqule, Inc. | Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof |
| FR3046792B1 (fr) * | 2016-01-19 | 2018-02-02 | Les Laboratoires Servier | Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN106243124B (zh) * | 2016-07-29 | 2018-03-09 | 湖北民族学院 | 一种噻吩并嘧啶脲类化合物及其制备方法和应用 |
| TW201811795A (zh) | 2016-08-24 | 2018-04-01 | 美商亞闊股份有限公司 | 胺基－吡咯并嘧啶酮化合物及其用途 |
| CN106810512B (zh) * | 2017-01-18 | 2019-09-10 | 江苏省中医药研究院 | Idh2突变体抑制剂及其用途 |
| AU2018317828A1 (en) * | 2017-08-15 | 2020-04-02 | AbbVie Deutschland GmbH & Co. KG | Macrocyclic MCL-1 inhibitors and methods of use |
| TW201920193A (zh) * | 2017-08-15 | 2019-06-01 | 美商艾伯維有限公司 | 大環ｍｅｌ-１抑制劑以及使用方法 |
| US10676485B2 (en) * | 2017-08-15 | 2020-06-09 | Abbvie Inc. | Macrocyclic MCL-1 inhibitors and methods of use |
| CA3152021A1 (en) | 2019-08-26 | 2021-03-04 | Chemwerth, Inc. | Substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino compounds useful as jak1 inhibitors |
| CN112500421B (zh) * | 2020-12-15 | 2021-08-24 | 河南科技大学第一附属医院 | 一种可用于杀菌消毒的苯并吡喃脲类化合物的制备方法及应用 |
| TW202413367A (zh) * | 2022-08-19 | 2024-04-01 | 財團法人國家衛生研究院 | Ｔａｍ受體抑制劑 |
| TW202508595A (zh) | 2023-05-04 | 2025-03-01 | 美商銳新醫藥公司 | 用於ｒａｓ相關疾病或病症之組合療法 |
| US20250049810A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| AU2024360465A1 (en) | 2023-10-12 | 2026-04-09 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| TW202547461A (zh) | 2024-05-17 | 2025-12-16 | 美商銳新醫藥公司 | Ｒａｓ抑制劑 |
| WO2025255438A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4008726A1 (de) * | 1990-03-19 | 1991-09-26 | Basf Ag | Thieno(2,3-d)pyrimidinderivate |
| AU9598601A (en) * | 2000-10-20 | 2002-04-29 | Eisai Co Ltd | Nitrogenous aromatic ring compounds |
| DE10141212A1 (de) | 2001-08-22 | 2003-03-06 | Bayer Ag | Neue 4-Aminofuropyrimidine und ihre Verwendung |
| AU2002333524A1 (en) | 2001-09-11 | 2003-03-24 | Glaxosmithkline K.K. | Furo-and thienopyrimidine derivatives as angiogenesis inhibitors |
| US6814324B2 (en) * | 2002-07-03 | 2004-11-09 | Segway Systems, Llc | Releasably latchable leader block in tape threading apparatus for data storage systems and method therefor |
| SI1847539T1 (sl) | 2002-12-24 | 2010-01-29 | Astrazeneca Ab | Kinazolinski derivati |
| JP4845736B2 (ja) * | 2003-10-14 | 2011-12-28 | アリゾナ ボード オブ リージェンツ オン ビハーフ ザ ユニバーシティー オブ アリゾナ | プロテインキナーゼ阻害剤 |
| US20050239806A1 (en) * | 2004-01-13 | 2005-10-27 | Ambit Biosciences Corporation | Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
| KR20050091462A (ko) | 2004-03-12 | 2005-09-15 | 한국과학기술연구원 | 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제 |
| AU2005243175B2 (en) | 2004-05-14 | 2011-12-01 | Millennium Pharmaceuticals, Inc. | Compounds and methods for inhibiting mitotic progression by inhibition of Aurora kinase |
| MXPA06015223A (es) | 2004-06-29 | 2007-11-09 | Amgen Inc | Furanopirimidinas. |
| JP2008505167A (ja) | 2004-07-05 | 2008-02-21 | アステックス、セラピューティックス、リミテッド | 医薬組成物 |
| CN101160316A (zh) * | 2004-07-16 | 2008-04-09 | 苏内西斯医药公司 | 适合用作aurora激酶抑制剂的噻吩并嘧啶 |
| MX2007000631A (es) * | 2004-07-16 | 2007-03-30 | Sunesis Pharmaceuticals Inc | Tienopirimidinas utiles como inhibidores de aurora cinasa. |
| US7932257B2 (en) * | 2005-07-22 | 2011-04-26 | Sunesis Pharmaceuticals, Inc. | Substituted pyrazolo[4,3-d]pyrimidines as aurora kinase inhibitors |
| DE102005037499A1 (de) * | 2005-08-09 | 2007-02-15 | Merck Patent Gmbh | Pyrazolderivate |
| PT1940844E (pt) * | 2005-10-28 | 2010-01-06 | Scripps Research Inst | Compostos e composições como inibidores de proteína-quinase |
| EA200870117A1 (ru) | 2005-12-23 | 2008-12-30 | Смитклайн Бичам Корпорейшн | Азаиндоловые ингибиторы аурора-киназ |
-
2009
- 2009-04-22 CN CN200980115577.4A patent/CN102014627B/zh not_active Expired - Fee Related
- 2009-04-22 JP JP2011507540A patent/JP5502072B2/ja active Active
- 2009-04-22 KR KR1020107025018A patent/KR101667822B1/ko active Active
- 2009-04-22 US US12/428,044 patent/US8138194B2/en active Active
- 2009-04-22 ES ES09739460.5T patent/ES2616255T3/es active Active
- 2009-04-22 AU AU2009241469A patent/AU2009241469B2/en not_active Ceased
- 2009-04-22 PL PL09739460T patent/PL2276346T3/pl unknown
- 2009-04-22 EP EP09739460.5A patent/EP2276346B1/en active Active
- 2009-04-22 DK DK09739460.5T patent/DK2276346T3/en active
- 2009-04-22 CA CA2722220A patent/CA2722220C/en active Active
- 2009-04-22 WO PCT/US2009/041382 patent/WO2009134658A2/en not_active Ceased
- 2009-04-29 TW TW098114168A patent/TWI363627B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL2276346T3 (pl) | 2017-07-31 |
| EP2276346A4 (en) | 2011-08-24 |
| US20090275533A1 (en) | 2009-11-05 |
| WO2009134658A3 (en) | 2009-12-30 |
| AU2009241469B2 (en) | 2015-05-07 |
| JP2011522789A (ja) | 2011-08-04 |
| HK1151694A1 (en) | 2012-02-10 |
| KR20100132067A (ko) | 2010-12-16 |
| CN102014627B (zh) | 2014-10-29 |
| DK2276346T3 (en) | 2017-02-27 |
| AU2009241469A1 (en) | 2009-11-05 |
| CA2722220C (en) | 2016-06-07 |
| JP5502072B2 (ja) | 2014-05-28 |
| WO2009134658A2 (en) | 2009-11-05 |
| CA2722220A1 (en) | 2009-11-05 |
| KR101667822B1 (ko) | 2016-10-19 |
| TW200948365A (en) | 2009-12-01 |
| EP2276346A2 (en) | 2011-01-26 |
| CN102014627A (zh) | 2011-04-13 |
| TWI363627B (en) | 2012-05-11 |
| EP2276346B1 (en) | 2016-11-23 |
| US8138194B2 (en) | 2012-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2616255T3 (es) | Compuestos de pirimidina bicíclicos condensados como inhibidores de las aurora cinasas | |
| ES2515194T3 (es) | Derivados de pirrolidina | |
| AR059512A1 (es) | Derivados de piridina -2- carboxamida | |
| AR076170A1 (es) | Derivados heterociclicos imidazolicos y/o oxazolicos utiles como agentes antivirales para hepatitis c y composiciones farmaceuticas que los comprenden. | |
| AR066379A1 (es) | Amidas de acido carboxilico su preparacion y su uso como medicamentos | |
| AR058776A1 (es) | Compuesto de piridina condensado | |
| ECSP11011200A (es) | Derivados de oxadiazale como agonista de los receptores s1p1 | |
| AR078320A1 (es) | Derivados nitrogenados heterociclicos inhibidores de tirosinquinasas de bruton(btk), formulaciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades autoinmunes, inflamatorias y canceres. | |
| AR055071A1 (es) | Derivados de pirrolo (3,2 - b) pirimidina. composiciones farmaceuticas. | |
| ES2607952T3 (es) | Derivados tricíclicos de Pirazol Amina | |
| CO6260132A2 (es) | Derivados de oxadiazol como inhibidores de dgat | |
| AR076164A1 (es) | Inhibidores de anillos fusionados de hepatitis c | |
| AR052558A1 (es) | Derivados de tiazol-4-carboxamida como antagonistas de mglur5 | |
| MX2017009625A (es) | Compuestos macrociclicos como inhibidores de cinasas asociadas al receptor de interleucina1/4 (irak1/4) y usos de los mismos. | |
| AR041170A1 (es) | Derivados de bencimidazol, benzoxazol y benzotiazol | |
| AR062110A1 (es) | Derivado de anillo fusionado de espiroquetas y su uso como farmaco antidiabetico | |
| AR061642A1 (es) | Derivados de ureas de tropano, su preparacion y su aplicacion en terapeu-tica, procesos de obtencion y composiciones farmaceuticas | |
| AR078641A1 (es) | Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas | |
| AR054612A1 (es) | Derivados de espiroquetas y composiciones farmaceuticas para su utilizacion como agente terapeutico para diabetes | |
| PE20080888A1 (es) | COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE LA ACIL-TRANSFERASA DE ACIL-CoA-DIACIL-GLICEROL 1 (DGAT1) | |
| PE20141586A1 (es) | Compuestos de heteroaril piridona y aza-piridona como inhibidores de actividad btk | |
| AR051995A1 (es) | Derivados de tieno-piridina como intensificadores alostericos de gaba -b | |
| AR078576A1 (es) | Amidas y tioamidas de diazol utiles para combatir parasitos animales, en particular insectos y procedimiento para prepararlas. | |
| CY1117862T1 (el) | Ετεροκυκλικες ενωσεις βενζοδιοξολιου ή βενζοδιοξεπινης ως αναστολεις φωσφοδιεστερασης | |
| AR068376A1 (es) | Amidas heterociclicas utiles para inhibir la via hedgehog. |